P PRESTIGE CONSMR HEALTHCARE I
| Market Cap | $2.52B |
| P/E Ratio | 13.85 |
| Forward P/E | 10.91 |
| Dividend Yield | — |
| Beta | 0.47 |
| 52W Range | $52.48 - $89.09 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Charles Bobrinskoy Ariel Investments | 2.73% | $253.08M | 4,102,497 | Add 14.12% |
| Robert Olstein Olstein Capital Management | 0.23% | $1.00K | 21,000 | — |
Insider Trading
| Insider Name of the company insider who made the trade 7 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Zerillo JeffreySenior VP Operations | Sale | 1,000 | $65.93 | $65.93K | 11 Feb 2026 | 13 Feb 2026 |
| Zerillo JeffreySenior VP Operations | Sale | 281 | $60.00 | $16.86K | 01 Dec 2025 | 02 Dec 2025 |
| Jeffrey ZerilloSenior VP Operations | Sale | 281 | $60.00 | $16.86K | 01 Dec 2025 | 02 Dec 2025 |
| Zerillo JeffreySenior VP Operations | Sale | 719 | $60.00 | $43.14K | 28 Nov 2025 | 02 Dec 2025 |
| Jeffrey ZerilloSenior VP Operations | Sale | 719 | $60.00 | $43.14K | 28 Nov 2025 | 02 Dec 2025 |
| BYOM JOHN E | Sale | 3,000 | $59.35 | $178.05K | 25 Nov 2025 | 26 Nov 2025 |
| John E ByomDirector | Sale | 3,000 | $59.35 | $178.05K | 25 Nov 2025 | 26 Nov 2025 |
Frequently Asked Questions
What is PBH stock price today?
PRESTIGE CONSMR HEALTHCARE I (PBH) is currently trading at $52.48. The stock has a 52-week range of $52.48 to $89.09 and a market capitalization of $2.52B.
Is PBH a good stock to buy in 2026?
PRESTIGE CONSMR HEALTHCARE I has a P/E ratio of 13.8 (forward P/E: 10.9), a dividend yield of none, and 1-year performance of -37.9%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling PBH stock?
There have been 7 insider transactions for PBH in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has PBH stock performed over the past year?
PRESTIGE CONSMR HEALTHCARE I (PBH) has returned -37.9% over the past 12 months. The stock traded between $52.48 and $89.09 during this period, and is currently at $52.48.
Which hedge funds own PBH (PRESTIGE CONSMR HEALTHCARE I)?
2 tracked hedge funds currently hold PBH in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is PBH's market cap and valuation?
PRESTIGE CONSMR HEALTHCARE I (PBH) has a market capitalization of $2.52B. The trailing P/E ratio is 13.8 and forward P/E is 10.9. The stock is classified in the Healthcare sector.
What is PBH's revenue and profitability?
PRESTIGE CONSMR HEALTHCARE I reported revenue of $1.10B with net income of $186.50M and a profit margin of 0.17%. The stock has a beta of 0.47.
What sector is PBH in and who are its biggest institutional holders?
PRESTIGE CONSMR HEALTHCARE I (PBH) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.